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Background: Insulin resistance is a major factor in the development of metabolic syndrome and is associated with central 
obesity and glucose intolerance. Resveratrol, a polyphenol found in fruits, has been shown to improve metabolic 
conditions. Although it has been widely studied how resveratrol affects metabolism, little is known about how resveratrol 
regulates lipogenesis with insulin signaling in 3T3-L1 adipocytes. 
Methods: We treated differentiated 3T3-L1 adipocytes with resveratrol to observe whether resveratrol is effective at 
reducing lipid accumulation. 
Results: Resveratrol treatment after mitotic clonal expansion resulted in decreased lipid accumulation accompanied 
by reduced fatty acid synthase expression. Decreased glucose uptake was observed with inhibited GLUT4 translocation 
in cells treated with 100 μM resveratrol, suggesting that high doses of resveratrol block insulin signaling in adipocytes. 
Insulin-stimulated Akt phosphorylation is also dose-dependently reduced with resveratrol treatment. Interestingly, 
Akt phosphorylation is upregulated when cells are treated with long-term low doses of resveratrol, suggesting that only 
low doses of resveratrol improve metabolic conditions. 
Conclusion: High doses of resveratrol block the insulin signaling pathway, thereby reducing glucose uptake and lipid 
accumulation in vitro. The results also provide information about in vivo administration dosages and may explain the 
discrepancy between in vitro and in vivo effects of resveratrol.
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INTRODUCTION
Obesity is a serious health problem associated with in-
creasing risk of various diseases including type 2 diabetes, 
hypertension, and coronary heart disease [1]. The imbalance 
between energy intake and expenditure results in increased 
size and number of adipocytes, which is believed to contrib-
ute to various metabolic abnormalities [2]. Thus, it is im-
portant to understand the mechanism of adipocyte differ-
entiation and lipid accumulation, as well as changes in in-
sulin-responsiveness as obesity progresses.
The murine 3T3-L1 cell line is an established insulin- 
responsive adipocyte model for studying adipogenesis [2,3]. 
When 3T3-L1 preadipocytes are treated with hormonal 
stimuli, they undergo differentiation to acquire the mature 
phenotype of adipocytes [4]. During adipocyte differentiation, 
transcriptional factors such as CCAAT/enhancer-binding 
proteins (C/EBPs) and peroxisome proliferator-activated re-
ceptor γ (PPARγ) are involved in the sequential expression 
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of adipocyte-specific proteins such as glucose transporter 4 
(GLUT4), aP2/422, stearoyl-CoA desaturase-1 (SCD-1) and 
fatty acid synthase (FAS) [5-7]. The GLUT4 expressed in 
mature adipocytes enables a dramatic increase of insulin- 
stimulated glucose uptake [8]. Adipogenic insulin signaling 
in adipocytes depends on several signaling molecules, in-
cluding insulin receptor substrate (IRS)-1 and -2, phosphoi-
nositide 3-kinase (PI3K), and Akt (or PKB) [9-12]. The 
theory that the insulin signal cascade is critical to mediate 
adipogenesis has been supported by the fact that several 
knockout mice models including insulin receptor or Akt ex-
hibited defective fat cell formation [13,14]. This suggests 
that the insulin signaling pathway is important both for adi-
pocyte differentiation and insulin sensitivity of mature 
adipocytes. 
Resveratrol, a polyphenol found in fruits, is a phytoalexin 
found in Polygonum capsidatum. The richest sources of this 
compound are peanuts, grapes, and red wine [15]. Previous 
studies have shown that resveratrol has beneficial effects in-
cluding anti-cancer, antioxidant, and cardioprotective prop-
erties, as well as the ability to protect cells from lipid accu-
mulation [16]. However, little is known about how resvera-
trol regulates lipogenesis with insulin signaling in 3T3-L1 
adipocytes. This study found that high-dose resveratrol in-
hibits the insulin signaling pathway with concomitant sup-
pression of glucose uptake, which resulted in reduced lipid 
accumulation in 3T3-L1 cells.
MATERIALS AND METHODS
1. Cell culture 
3T3-L1 preadipocytes were propagated and maintained in 
DMEM containing 10% calf serum. To induce differ-
entiation, 2-day postconfluent 3T3-L1 preadipocytes 
(designated day 0) were fed DMEM containing 10% FBS, 
1 μg/ml insulin (I), 1 μM dexamethasone (D), and 0.5 mM 
3-isobutyl-methylxanthine (M) until day 2. Cells were then 
fed DMEM supplemented with 10% FBS and 1 μg/ml in-
sulin for two days, after which they were fed every other 
day with DMEM containing 10% FBS. 
2. Glucose uptake assay
On day 8 of differentiation, resveratrol (Sigma) was add-
ed to the cells. After 3 h, adipocytes were incubated with 
100 nM insulin at 37oC for 20 min. Cells were then washed 
twice with warm KRP buffer, pH 7.4 (128 mM NaCl, 4.7 
mM KCl, 1.25 mM MgSO4, 1.25 mM CaCl2, 20 mM 
NaH2PO4). A mixture of KRP buffer containing 1 mM 
2-deoxyglucose and 0.2 μCi/l 2-deoxy- D-[14C] glucose was 
made and added to the cells for 10 min at room 
temperature. Then, the medium was aspirated and the plates 
were washed with ice-cold PBS to terminate the induced 
glucose uptake. The cells were lysed and radioactivity taken 
up by the cells was determined using a scintillation counter.
3. Western blotting
At the indicated time points, cell monolayers (6-cm 
dishes) were washed once with cold phosphate-buffered sal-
ine (PBS) (pH 7.4) and then scraped into lysis buffer con-
taining 1% SDS and 60 mM Tris-HCl (pH 6.8). Lysates 
were heated at 100oC for 10 min and clarified by 
centrifugation. Equal amounts of protein were subjected to 
SDS-PAGE and transferred to a nitrocellulose membrane. 
The membrane was probed with the following primary anti-
bodies: polyclonal rabbit anti-IRS-1 (upstate), polyclonal 
mouse anti-Akt (upstate), polyclonal anti-phospho Akt 
(Cell signaling), polyclonal anti-rabbit phosphor rabbit 
m-TOR (Cell signaling), polyclonal anti-mouse PPARγ, poly-
clonal anti-rabbit SIRT1 (Santacruz CA, USA), ACCα and 
FAS (gift from Dr. Kyung-Sup Kim, Yonsei University 
College of Medicine). The blots were incubated in the ap-
propriate peroxidase-conjugated secondary antibody, and 
immunoreactivity was visualized by enhanced chem-
iluminescence.
4. Oil red-O staining
3T3-L1 preadipocytes were induced to differentiation as 
described above. At day 8 differentiated adipocytes were 
washed three times with PBS and then fixed for 2 min with 
3.7% formaldehyde. Oil red-O (0.5% in isopropanol) was di-
luted with water (3:2), filtered through a 0.45 μm filter, 
and incubated with the fixed cells for 1 h at room 
temperature. Cells were washed with water, and the stained 
fat droplets in the adipocytes were visualized by light 
microscopy.
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Fig. 1. Resveratrol inhibits lipogenesis in 3T3-L1 adipocytes. (A)
Confluent 3T3-L1 preadipocytes were induced to differentiate as 
described in Materials and Methods. After 2 days of differen-
tiation, 3T3-L1 cells were treated with various amounts of 
resveratrol (a, 0.1% DMSO; b, 50 μM; c, 100 μM) for 3 days.
After 8 days, cells were fixed in formaldehyde, and stained with 
oil Red-O to determine the degree of adipocyte differentiation. 
(B) Resveratrol represses the expression of adipogenic gene in 
3T3-L1 adipocytes. Confluent 3T3-L1 preadipocytes were induced
to differentiate as described. After 2 days of differentiation, 3T3-
L1 cells were treated with various amount of resveratrol for 2 
or 3 days and total cell extracts were prepared at the indicated
time for Western blot analyses.
5. Confocal microscopy
3T3-L1 cells were grown on glass coverslips (18-mm di-
ameter) placed in 12-well plates. Cells were cultured with 
or without 50 μM or 100 μM resveratrol for 3 h. Cells 
were treated with 100 nM insulin for 20 min at 37oC, fixed 
with 3.7% formaldehyde for 20 min, and permeabilized with 
0.1% Triton X-100 for 20 min. The cells were blocked with 
1% BSA in PBS with 0.1% Tween-20 for 1 h. The blocking 
solution was removed and the primary antibody against 
GLUT4 (Santacruz) was incubated for 1 h, and then in-
cubated with Cy3-conjugated goat antimouse secondary an-
tibodies for 1 h. Samples were washed with PBS and mount-
ed onto glass slides, and image was taken with a Carl Zeiss 
LSM510 confocal microscope. 
RESULTS
1. Resveratrol inhibited lipid accumulation in 3T3-L1 
adipocytes
Upon hormonal stimuli, growth-arrested 3T3-L1 pre-
adipocytes rapidly reenter the cell cycle and undergo two 
or more rounds of mitotic clonal expansion in 2 days of dif-
ferentiation induction [5]. In this period, cells begin to ex-
press C/EBPβ, C/EBPδ, and other transcription factors to 
activate the gene expression of two pleotropic transcription 
factors, C/EBPα and PPARγ, which are responsible for 
the acquisition of mature phenotype of adipocytes [17]. We 
previously reported that resveratrol inhibits adipogenesis by 
modulating the amount of reactive oxygen species, which 
blocks the C/EBPβ activation process [18]. In order to in-
vestigate the effect of resveratrol in lipid accumulation of 
adipocytes, the differentiating 3T3-L1 cells were treated 
with resveratrol after two days of differentiation induction, 
which may exclude the effect of resveratrol on mitotic clo-
nal expansion (Fig. 1A). As a result, treatment of 50 μM 
or 100 μM resveratrol markedly reduced lipid accumu-
lation in cells in a dose-dependent manner as shown by 
oil-red O staining (Fig. 1B). Consistent with these morpho-
logical changes, the expression of adipogenic genes includ-
ing acetyl CoA carboxylase (ACC) α, fatty acid synthase 
(FAS), and PPARγ was significantly decreased with high 
doses (100 μM) of resveratrol over the course of 2-3 days 
(Fig. 1C). Because the expression of C/EBPα and PPARγ 
begins after approximately 36 h of differentiation induction, 
it is assumed that the resveratrol treatment protocol in this 
study does not affect differentiation per se, but instead it 
appears that the treatment may reduce the accumulation of 
lipid after differentiation. Moreover, reduced expression of 
lipogenic genes such as ACCα and FAS indicates that re-
sveratrol inhibits lipid accumulation by inhibiting of genes 
involved in the lipogenesis process. 
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Fig. 2. The effect of resveratrol on glucose transport in 3T3-L1 adipocytes. (A) Resveratrol inhibits glucose uptake in 3T3-L1 adipocytes. 
3T3-L1 cells were differentiated into adipocytes as described in Materials and Methods. After 8 days of differentiation, 3T3-L1 cells 
were pretreated with or without 50 μM resveratrol (RSV 50) or 100 μM resveratrol (RSV 100) for 3 h in the presence or absence 
of insulin (100 nM). Glucose uptake was measured as described in Materials and Methods. The results represent the means ± SD 
for two independent assays in triplicate (*p ＜ 0.01; compared with control). (B) After 8 days of differentiation, cells were treated 
with insulin in the presence or absence of resveratrol (RSV). The treated cells were fixed and immunostained with a GLUT4 antibody 
and photographed with confocal microscope. Arrows indicate sites of GLUT4 membrane translocation.
2. Resveratrol suppressed glucose transport in 3T3-L1 
adipocytes
It was well documented that insulin stimulates glucose up-
take by GLUT4 translocation and lipogenesis [19,20]. We 
measured 2-deoxy[14C] glucose uptake in 3T3-L1 adipocytes 
to test whether the effects on mature 3T3-L1 adipocytes are 
dependent on insulin signaling. Differentiated 3T3-L1 adi-
pocytes (day 8) were treated with or without 50 μM or 
100 μM resveratrol for 3 h (Fig. 2A). Compared to the 
control cells (2 fold-increase of glucose uptake by insulin), 
glucose uptake in the cells pretreated with 50 and 100 μM 
resveratrol for a short time (3 h) was reduced by 32% and 
51%, respectively. 
The effector of the insulin-induced glucose transport in 
adipocyte is GLUT4 [21]. Next, an immunofluorescence as-
say was performed to determine whether resveratrol influ-
ences GLUT4 translocation. The control cells translocated 
GLUT4 to the plasma membrane in response to insulin (Fig. 
2B). In contrast, cells pretreated by resveratrol (100 μM) 
did not show definite translocation of GLUT4, indicating 
that resveratrol can reduce glucose uptake and inhibit 
GLUT4 translocation, which may result in reduced lipid ac-
cumulation in 3T3-L1 adipocytes. These data suggest that 
high doses of resveratrol do not improve insulin sensitivity, 
but instead block insulin signaling and glucose uptake in 
3T3-L1 adipocytes.
3. Resveratrol inhibits Akt and Akt downstream tar-
gets in 3T3-L1 adipocytes
It has been previously demonstrated that Akt signaling is 
linked to the translocation of GLUT4 to the plasma mem-
brane, resulting in the stimulation of glucose uptake by in-
sulin [22], and leading to activation of mammalian target 
of rapamycin (mTOR). To determine the effect of resvera-
trol on insulin signaling, 3T3-L1 adipocytes were pre-treat-
ed with or without resveratrol in the short-term (3 h) or 
long-term (16 h) before insulin stimulation. As a result, a 
short-term treatment of resveratrol repressed insulin signal-
ing by decreasing Akt phosphorylation and inhibiting the 
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Fig. 3. Resveratrol inhibits insulin signaling pathway in 3T3-L1 
adipocytes. 3T3-L1 cells were differentiated into adipocytes as
described in Materials and Methods. (A) After 8 days of differen-
tiation, 3T3-L1 cells were pretreated with or without 50 μM
resveratrol (RSV 50) or 100 μM resveratrol (RSV 100) for 3 h 
and then exposed to 100 nM insulin for 20 min. Total cell 
extracts were prepared at the indicated times for Western blot 
analyses. (B) Confluent cells were pretreated with or without 50
μM resveratrol (RSV 50) or 100 μM resveratrol (RSV 100) for
3 h or 16 h and then exposed to 100 nM insulin for 20 min. 
Total cell extracts were prepared at the indicated times for 
Western blot analyses.
kinase activity of mTOR (Fig. 3A). Long-term resveratrol 
treatment had a different effect on the phosphorylation of 
Akt (Fig. 3B). Akt phosphorylation was gradually increased 
in a dose-dependent manner (1-50 μM), but then de-
creased at high doses (100 μM). The protein of SirT1 was 
not affected by resveratrol (Fig. 3A). These results suggest 
that short-term high doses of resveratrol cause down-regu-
lation of Akt and mTOR on insulin signaling and will not 
improve insulin sensitivity. The results also show that long- 
term treatment with low doses of resveratrol may help con-
trol metabolic syndrome.
DISCUSSION
Many reports have implicated the role of the insulin sig-
naling pathway; including insulin receptors, IRS-1 and -2, 
PI3K and Akt; in insulin-induced adipogenesis and in-
sulin-stimulated glucose uptake [9-12]. Binding of insulin to 
its receptor triggers the phosphorylation of insulin receptor 
substrate (IRS) proteins. Tyrosine phosphorylated IRS pro-
teins recruit and sequentially activate phosphoinositide 3 
kinase (PI3K) and protein kinase B (PKB, also known as 
AKT) [23,24]. Several knockout mice models including in-
sulin receptor, Akt, and PI3K exhibit defective fat cell for-
mation [13,25], probably by inhibiting insulin-like growth 
factor (IGF) signaling. Thus, it is important to carefully 
consider whether a certain chemical affects fat cell for-
mation or lipid accumulation. There are a number of studies 
about the beneficial effects of resveratrol on metabolism, 
but it has also been previously reported that resveratrol in-
hibits insulin signaling, including MAPK and Akt activation 
[16,26] and PI3K [27]. Although mild inhibition of insulin 
signaling is associated with increased life span [26], it re-
mains unclear why resveratrol has beneficial effects on met-
abolic diseases.
We previously reported that reactive oxygen species facil-
itate adipocyte differentiation by accelerating mitotic clonal 
expansion [18]. Resveratrol acted as an anti-oxidant, in-
hibiting the gradual increase of reactive oxygen species 
which is essential for the C/EBPβ activation. This was 
shown to be a SIRT1-independent pathway, and was also 
observed with other anti-oxidants such as genistein, epi-
gallocatechin 3-gallate, and N-acetyl cysteine. Thus, as an 
anti-oxidant, resveratrol affects mitotic clonal expansion 
and adipocyte differentiation. This study focused on the ef-
fect of resveratrol on the insulin signaling pathway and lipid 
accumulation, so treatment with resveratrol was carried out 
after mitotic clonal expansion. Particularly, the glucose up-
take assay was performed with fully differentiated adipo-
cytes (Fig. 2). Because white adipose tissue is thought to 
be one of the major sites of metabolic derangements, the 
effect of resveratrol on glucose uptake in adipocytes was 
analyzed for evidence of insulin resistance. Results from the 
present study demonstrated that resveratrol inhibits glucose 
uptake and GLUT4 translocation via down-regulation of 
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Akt on insulin signaling in 3T3-L1 adipocytes. The reduced 
glucose uptake might result in decreased formation of fatty 
acids, which is a major source of fat accumulation in 
3T3-L1 adipocytes. Accumulation of fat depends on the bal-
ance between fat synthesis (lipogenesis) and breakdown 
(fatty acid oxidation). Fatty acid synthase (FAS) and ace-
tyl-CoA carboxylase (ACC) are the major enzymes regulat-
ing fat synthesis [28,29]. For example, inhibition of ACC, 
which catalyzes the conversion of acetyl-CoA to ma-
lonyl-CoA. This is the rate-limiting step of fatty acid 
biosynthesis. FAS is a multifunctional enzyme that catalyzes 
the synthesis of long-chain fatty acids. In the present study, 
resveratrol suppressed lipid droplet accumulation as well as 
FAS and ACC expression. It is not clear whether resveratrol 
directly regulated FAS expression. Reduced glucose uptake 
might have contributed to decreased lipid accumulation, but 
it is also possible that resveratrol affected adipocyte differ-
entiation, which is not associated with insulin signaling. 
Nevertheless, high doses of resveratrol are clearly associated 
with GLUT4 translocation issues in mature adipocytes.
Resveratrol treatment leads to activation of SIRT1 both 
in vivo and in vitro [16,30]. There is some evidence that 
SIRT1 is involved in energy metabolism control and has a 
lipid-lowering effect through AMPK stimulation [25,31,32]. 
The present study demonstrated that inhibition of Akt acti-
vation in parallel with a reduction in the translocation of 
GLUT4 with resveratrol suppresses lipogenesis in SIRT-in-
dependent pathway. Previous and current data demonstrated 
that in vitro high doses of resveratrol inhibited adipogenesis, 
glucose uptake, and insulin signaling. These results suggest 
that resveratrol has different features according to dose and 
time period, and additional research is necessary to de-
termine whether or not resveratrol is beneficial to human 
health.
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